GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Beginning Cash Position

Theriva Biologics (FRA:SFY) Beginning Cash Position : €21.42 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics Beginning Cash Position?

Theriva Biologics's Beginning Cash Position for the quarter that ended in Mar. 2024 was €21.42 Mil.

Theriva Biologics's quarterly Beginning Cash Position declined from Sep. 2023 (€32.19 Mil) to Dec. 2023 (€28.66 Mil) and declined from Dec. 2023 (€28.66 Mil) to Mar. 2024 (€21.42 Mil).

Theriva Biologics's annual Beginning Cash Position increased from Dec. 2021 (€5.51 Mil) to Dec. 2022 (€63.55 Mil) but then declined from Dec. 2022 (€63.55 Mil) to Dec. 2023 (€38.41 Mil).

Theriva Biologics Beginning Cash Position Historical Data

The historical data trend for Theriva Biologics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Beginning Cash Position Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.03 12.37 5.51 63.55 38.41

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.12 33.39 32.19 28.66 21.42

Theriva Biologics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Theriva Biologics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Theriva Biologics (FRA:SFY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Beginning Cash Position
Comparable Companies
ADIL GTBP PRTG FRTX SILO PCSA SONN LIXT AZTR SNPX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TOVX:USA
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Website
https://www.therivabio.com
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-25-2022

SoFi Releases SoFi Gig Economy ETF (GIGE) and SoFi 50 ETF (SFYF)

By PRNewswire PRNewswire • 05-08-2019